Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Astrana HealthASTH +1.55%85 Shiller PE Ratio is 71.62 as of Aug. 22, 2026, which is 54% below its 10-year median of 154.56. GuruFocus rates ASTH with a GF Score™ of 85/100 and a GF Value™ of $65.95 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 239 Healthcare Providers & Services companies, Astrana Health ranks worse than 86.61% on this metric.
As of today (2026-08-22), Astrana Health's current share price is $39.39. Astrana Health's E10 for the quarter that ended in Jun. 2026 was $0.55. Astrana Health's Shiller PE Ratio for today is 71.62.
The historical rank and industry rank for Astrana Health's Shiller PE Ratio or its related term are showing as below:
ASTH'
s Shiller PE Ratio Range Over the Past 10 Years
Min: 52.19 Med: 154.56 Max: 1043.75
Current: 71.18
During the past years, Astrana Health's highest Shiller PE Ratio was 1043.75. The lowest was 52.19. And the median was 154.56.
ASTH's Shiller PE Ratio is ranked worse than 86.61% of 239
companies
in the Healthcare Providers & Services industry
Industry Median: 23.89
vs ASTH: 71.18
E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.
Astrana Health's adjusted earnings per share data for the three months ended in Jun. 2026 was $0.400. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $0.55 for the trailing ten years ended in Jun. 2026.
Shiller PE for Stocks: The True Measure of Stock Valuation
Astrana Health (NAS:ASTH) Shiller PE Ratio Explanation
Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.
Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.
Be Aware
Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.
Astrana Health Shiller PE Ratio Related Terms
Astrana Health Shiller PE Ratio Historical Data
* Premium members only.
The historical data trend for Astrana Health's Shiller PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASTH vs SNDA, SGRY, AVAH: Shiller PE Ratio Comparison
For the Medical Care Facilities subindustry, Astrana Health's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Astrana Health Shiller PE Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Astrana Health's Shiller PE Ratio distribution charts can be found below:
* The bar in red indicates where Astrana Health's Shiller PE Ratio falls into.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.
Astrana Health's Shiller PE Ratio for today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Astrana Health's E10 for the quarter that ended in Jun. 2026 is calculated as:
For example, Astrana Health's adjusted earnings per share data for the three months ended in Jun. 2026 was:
Add all the adjusted EPS together and divide 10 will get our E10.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Astrana Health (ASTH) has a Shiller PE Ratio of 71.62 as of Aug. 22, 2026. Shiller price-earnings ratio is the ratio of share price to a company's inflation-adjusted earnings over a 10-year period. View historical data on Astrana Health and its competitors. This is 54% below median its historical median of 154.56. Over the past decade, Astrana Health's Shiller PE Ratio has ranged from 52.19 to 1,043.75. According to the industry distribution chart, Astrana Health ranks #207 out of 239 companies in the Healthcare Providers & Services industry, placing it in the top 86.6%.
Is Astrana Health's Shiller PE Ratio too high?
Astrana Health's current Shiller PE Ratio of 71.62 is 54% below median its 10-year median of 154.56. Over the past 10 years, this metric has ranged from a low of 52.19 to a high of 1,043.75. The Healthcare Providers & Services industry median Shiller PE Ratio is 23.89. Astrana Health's value of 71.62 is 199.8% above this industry median. Based on the distribution chart, Astrana Health ranks #207 out of 239 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Astrana Health has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astrana Health's Shiller PE Ratio compare to SNDA and SGRY?
According to the Healthcare Providers & Services industry distribution chart, Astrana Health ranks #207 out of 239 companies for Shiller PE Ratio. This places Astrana Health in the lower half of its industry. The industry median Shiller PE Ratio is 23.89. Astrana Health's value of 71.62 is 199.8% above this benchmark. Historically, Astrana Health's own Shiller PE Ratio has ranged from 52.19 to 1,043.75 over the past decade. While the company's 10-year median is 154.56 vs. the industry median of 23.89, Astrana Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shiller PE Ratio for a Healthcare Providers & Services company?
The median Shiller PE Ratio among Healthcare Providers & Services companies is 23.89, based on 239 companies in the industry. Companies in the top quartile (top 25%) have a Shiller PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Shiller PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Astrana Health's current Shiller PE Ratio of 71.62 is 199.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shiller PE Ratio mean?
A high Shiller PE Ratio can signal that a stock is expensive relative to its fundamentals. Shiller price-earnings ratio is the ratio of share price to a company's inflation-adjusted earnings over a 10-year period. View historical data on Astrana Health and its competitors. For the Healthcare Providers & Services industry, the median Shiller PE Ratio is 23.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Astrana Health's current Shiller PE Ratio is 71.62, which is 54% below median its own 10-year median of 154.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astrana Health stock overvalued right now?
Based on GuruFocus' analysis, Astrana Health (ASTH) is currently considered Significantly Undervalued. The stock's GF Value™ is $65.95, compared to a current price of $39.39 — trading 40.3% below its estimated fair value. The current Shiller PE Ratio is 71.62, which is 54% below median its 10-year median of 154.56 and 199.8% above the Healthcare Providers & Services industry median of 23.89. Astrana Health's overall GF Score™ is 85/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shiller PE Ratio calculated?
Shiller PE Ratio is calculated from a company's financial statements. For Astrana Health (ASTH), the current Shiller PE Ratio is 71.62 as of Aug. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Astrana Health (ASTH) Overvalued in 2026?
Based on GuruFocus' analysis, Astrana Health stock appears to be undervalued.
The current stock price of $39.39 is trading 40.3% below its estimated GF Value™ of $65.95.
GuruFocus considers Astrana Health to be Significantly Undervalued.
Key valuation signals for ASTH:
Shiller PE Ratio: 71.62 (54% below median its 10-year median of 154.56)
GF Value™: $65.95 vs. price of $39.39 (40.3% below fair value)
Industry Position: 199.8% above the Healthcare Providers & Services median (#207 of 239)
No single metric tells the full story. See the ASTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
85GF Score
Get the complete analysis for ASTH
Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASTH has been successfully added to your 
